10 High Growth Stocks Insiders Are Buying
Insider buying tends to get attention because it signals that company executives are putting personal capital behind their own businesses.
Zura Bio Ltd (ZURA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 9,443,001 | $55,713,706 | +5% | 1.02% |
| 2. | BioImpact Capital Mpm Capital | 4,472,843 | $26,389,774 | 1.61% | |
| 3. | Great Point Partners Jeffrey Jay And David Kroin | 4,215,930 | $24,873,987 | 4.7% | |
| 4. | Braidwell LP Alex Karnal | 3,980,295 | $23,483,741 | -1% | 0.87% |
| 5. | Siren L.L.C. Raymond Debbane | 3,734,866 | $22,035,709 | 0.45% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.25 | 2,000,000 | $12,500,000.00 | 6,552,725 | 2026-02-26 | Filing | |
| $6.20 | 80,000 | $496,000.00 | 100,000 | 2024-05-17 | Filing | |
| $3.13 | 7,987 | $24,999.31 | 7,987 | 2024-04-22 | Filing | |
| $3.13 | 3,195 | $10,000.35 | 3,195 | 2024-04-22 | Filing | |
| $3.13 | 159,744 | $499,998.72 | 777,384 | 2024-04-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.73 | 1,001,633 | $2,734,458.09 | 0 | 2024-11-25 | Filing | |
| $2.70 | 3,800,000 | $10,260,000.00 | 1,001,633 | 2024-09-11 | Filing | |
| $3.87 | 51,728 | $200,187.36 | 2,085,418 | 2024-09-04 | Filing | |
| $4.00 | 2,000,000 | $8,000,000.00 | 4,801,633 | 2023-12-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,434,990 | $37,966,441 | 1.15% | |
| 2. | 4,354,715 | $24,517,046 | 0% | |
| 3. | 3,614,695 | $21,326,701 | 0% | |
| 4. | 1,584,209 | $9,348,520 | 0% | |
| 5. | 1,464,303 | $8,639,388 | 0.39% |
News See All
Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress
The reaffirmed outlook came as Zura Bio Limited (NASDAQ:ZURA) reported its results for Q3 2025 on the same day.
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
13 Penny Stocks with Insider Buying in 2024
Insider transactions have always drawn market attention as it's now a well-known fact that when insiders are piling into a stock, the odds of it going higher in the future are pretty bright.
Hedge Fund Resource Center